Alzheimer's Research and Treatment Center
Wellington, Florida, United States
Doctor in Wellington, Florida
2767 S State Rd 7 Suite 300, Wellington, FL 33414
About Alzheimer's Research and Treatment Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Alzheimer's Research and Treatment Center
During the past decade, Alzheimer's Research and Treatment Center conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 14 clinical trials were completed, i.e. on
average, 46.7% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 12 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis
2008-07-17
2023-12-16
Active, not recruiting
220
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
2011-03-02
2022-12-31
Completed
735
A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132)
2016-04-30
2022-12-13
Completed
578
A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD).
2016-03-22
2019-05-31
Terminated
813
A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2018-08-10
2024-03-31
Active, not recruiting
135
Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Sclerosis
2018-11-12
2025-07-26
Active, not recruiting
1,700
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
2020-11-26
2029-03-30
Recruiting
865
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
2020-10-26
2026-12-18
Recruiting
946
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Alzheimer's Research and Treatment Center" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Eisai Inc." with 3 trials
sponsored, "Neurotrope Bioscience, Inc." with 3 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 3 trials sponsored and "Eli Lilly and Company"
with 3 trials sponsored. Other sponsors include 10 different institutions and
companies that sponsored additional 18 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Alzheimer's Research and Treatment Center"
#1 collaborator was "National Institute on Aging (NIA)" with 4 trials as a collaborator, "Biogen" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Alzheimer's Association" with 1 trials as a collaborator and "Alzheimer's Clinical Trials Consortium" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were
collaborators in the rest 10 trials.
Clinical Trials Conditions at Alzheimer's Research and Treatment Center
According to Clinical.Site data, the most researched conditions in "Alzheimer's Research and Treatment Center" are
"Alzheimer Disease" (13 trials), "Alzheimer's Disease" (11 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials), "Early Alzheimer's Disease" (2 trials) and "Agitation in Participants With Dementia of the Alzheimer's Type" (1 trials). Many other conditions were trialed in "Alzheimer's Research and Treatment Center" in a lesser frequency.
Clinical Trials Intervention Types at Alzheimer's Research and Treatment Center
Most popular intervention types in "Alzheimer's Research and Treatment Center" are "Drug" (33 trials), "Other" (4 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (28 trials), "Gantenerumab" (5 trials), "Crenezumab" (3 trials), "AVP-786" (2 trials) and "Bryostatin 1" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Alzheimer's Research and Treatment Center
The vast majority of trials in "Alzheimer's Research and Treatment Center" are
34 trials for "All" genders.
Clinical Trials Status at Alzheimer's Research and Treatment Center
Currently, there are NaN active trials in "Alzheimer's Research and Treatment Center".
undefined are not yet recruiting,
6 are recruiting,
5 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 13 completed trials in Alzheimer's Research and Treatment Center,
undefined suspended trials,
and 10 terminated clinical trials to date.
Out of the total trials that were conducted in Alzheimer's Research and Treatment Center, 3 "Phase 1"
clinical trials were conducted, 14 "Phase 2" clinical
trials and 20 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".